3 days after the stroke, Iba-1- and CD68-positive cells were detected in the ischemic brain tissue, although the number of these cells was largely decreased after LAM (dectin-1 antagonist) treatment (Fig. 6a, b). This evidence concerns the gene CLEC7A and stroke disorder.